The pain point is clear: developing new disease-resistant crop varieties is a slow, expensive gamble. Traditional breeding and field trials can take a decade, leaving crops—and revenue—vulnerable to evolving pathogens and climate stress. This R&D bottleneck stifles innovation and exposes food supply chains to significant risk, making it difficult for seed companies to respond to market demands or emerging threats with agility.













